New Key Statistics Module, Z-Score and F-Score
NYSE:RDY Key Ratios
Market Cap $ M | 12,524.72 |
Enterprise Value $ M | 11,895.01 |
P/E(ttm) | 20.26 |
PE Ratio without NRI | 21.26 |
Forward PE Ratio | 20.79 |
Price/Book | 3.95 |
Price/Sales | 3.90 |
Price/Free Cash Flow | 36.87 |
Price/Owner Earnings | 17.92 |
Payout Ratio % | 0.13 |
Revenue (TTM) $ M | 3,279.00 |
EPS (TTM) $ | 3.79 |
Beneish M-Score | -2.34 |
10-y EBITDA Growth Rate % | 5.90 |
5-y EBITDA Growth Rate % | 18.90 |
y-y EBITDA Growth Rate % | 21.70 |
EV-to-EBIT | 14.24 |
EV-to-EBITDA | 11.84 |
PEG | 1.12 |
Shares Outstanding M | 166.53 |
Net Margin (%) | 19.24 |
Operating Margin % | 23.99 |
Pre-tax Margin (%) | 25.47 |
Quick Ratio | 1.90 |
Current Ratio | 2.55 |
ROA % (ttm) | 15.48 |
ROE % (ttm) | 21.44 |
ROIC % (ttm) | 21.95 |
Dividend Yield % | 0.65 |
Altman Z-Score | 8.81 |
RDY Number of Guru Trades
RDY Volume of Guru Trades
Gurus Latest Trades with NYSE:RDY
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
NYSE:RDY is held by these investors
Total 1
Dr Reddy's Laboratories Ltd Insider Transactions
No Available Data
News about NYSE:RDY
Total 0- 1